Free Trial

Tudor Investment Corp ET AL Sells 60,770 Shares of Arcosa, Inc. $ACA

Arcosa logo with Construction background
Image from MarketBeat Media, LLC.

Key Points

  • Tudor Investment Corp ET AL cut its Arcosa stake by 74.5%, selling 60,770 shares and leaving 20,762 shares valued at about $1.946 million after the 3rd-quarter 13F filing.
  • Arcosa beat quarterly EPS estimates ($1.15 vs. $0.95) and saw revenue rise 7.6% year-over-year despite a slight revenue miss, with analysts forecasting full-year EPS of about 3.23.
  • The company announced a quarterly dividend of $0.05 (annualized $0.20, ~0.2% yield), and Wall Street consensus is a Moderate Buy with an average price target of $120.00.
  • Interested in Arcosa? Here are five stocks we like better.

Tudor Investment Corp ET AL lowered its position in shares of Arcosa, Inc. (NYSE:ACA - Free Report) by 74.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,762 shares of the company's stock after selling 60,770 shares during the period. Tudor Investment Corp ET AL's holdings in Arcosa were worth $1,946,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in ACA. Capital International Investors lifted its stake in Arcosa by 28.3% during the third quarter. Capital International Investors now owns 2,228,275 shares of the company's stock worth $208,812,000 after purchasing an additional 491,165 shares during the last quarter. Vaughan Nelson Investment Management L.P. bought a new stake in Arcosa during the third quarter worth about $37,035,000. Bank of America Corp DE lifted its stake in Arcosa by 80.5% during the second quarter. Bank of America Corp DE now owns 465,140 shares of the company's stock worth $40,332,000 after purchasing an additional 207,457 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in Arcosa by 25.3% during the second quarter. The Manufacturers Life Insurance Company now owns 763,557 shares of the company's stock worth $66,208,000 after purchasing an additional 154,172 shares during the last quarter. Finally, Qube Research & Technologies Ltd lifted its stake in Arcosa by 130.2% during the third quarter. Qube Research & Technologies Ltd now owns 182,027 shares of the company's stock worth $17,058,000 after purchasing an additional 102,953 shares during the last quarter. Institutional investors own 90.66% of the company's stock.

Arcosa Trading Up 0.0%

NYSE ACA opened at $111.64 on Monday. The stock has a 50-day moving average of $113.71 and a 200-day moving average of $107.07. The firm has a market cap of $5.48 billion, a PE ratio of 26.33, a price-to-earnings-growth ratio of 1.46 and a beta of 0.96. The company has a current ratio of 2.20, a quick ratio of 1.35 and a debt-to-equity ratio of 0.57. Arcosa, Inc. has a 1-year low of $73.93 and a 1-year high of $131.00.

Arcosa (NYSE:ACA - Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The company reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $0.95 by $0.20. The business had revenue of $716.70 million during the quarter, compared to analyst estimates of $719.46 million. Arcosa had a return on equity of 8.64% and a net margin of 7.23%.Arcosa's quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.46 EPS. As a group, sell-side analysts forecast that Arcosa, Inc. will post 3.23 EPS for the current year.

Arcosa Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Wednesday, April 15th will be issued a dividend of $0.05 per share. The ex-dividend date is Wednesday, April 15th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.2%. Arcosa's dividend payout ratio is 4.72%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Weiss Ratings lowered Arcosa from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Thursday. Texas Capital raised Arcosa to a "strong-buy" rating in a research note on Friday, March 27th. DA Davidson lifted their price target on Arcosa from $120.00 to $125.00 and gave the stock a "buy" rating in a research note on Monday, March 2nd. Finally, Wall Street Zen lowered Arcosa from a "buy" rating to a "hold" rating in a research note on Sunday, March 1st. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $120.00.

View Our Latest Research Report on ACA

About Arcosa

(Free Report)

Arcosa, Inc NYSE: ACA is a Dallas‐based industrial company that was formed through the spin‐off of Trinity Industries' construction products business in 2018. Since its inception, Arcosa has focused on the manufacture and sale of critical infrastructure components, serving a diverse set of end markets including transportation, construction and energy.

The company's Construction Products segment produces a broad range of highway safety products, such as guardrail systems, sign supports and crash cushions, as well as aggregates and ready‐mix concrete.

Read More

Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA - Free Report).

Institutional Ownership by Quarter for Arcosa (NYSE:ACA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arcosa Right Now?

Before you consider Arcosa, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arcosa wasn't on the list.

While Arcosa currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines